Myocardial 18F-FDG Uptake After Exercise-induced Myocardial Ischemia in Patients with Coronary Artery Disease
Overview
Affiliations
Unlabelled: We have recently demonstrated the potential of (18)F-FDG as an imaging marker of myocardial ischemia if injected at peak exercise. However, how long increased (18)F-FDG uptake can be observed after an episode of exercise-induced myocardial ischemia is not known. We performed the current study to determine whether increased regional myocardial (18)F-FDG uptake at exercise in patients with coronary artery disease (CAD) persists on rest imaging (24 h later), after an episode of exercise-induced myocardial ischemia.
Methods: Twenty-four patients with suspected CAD underwent exercise (99m)Tc-sestamibi and (18)F-FDG imaging. Repeated (18)F-FDG imaging was performed 24 h after exercise imaging, after an injection of a second dose of (18)F-FDG at rest in 20 patients. Perfusion imaging with (99m)Tc-sestamibi was simultaneously performed with (18)F-FDG imaging. All patients underwent coronary angiography.
Results: Eighteen patients had greater than or equal to 70% luminal narrowing of 1 or more coronary vessels. Fifteen patients (83%) showed increased regional (18)F-FDG uptake on exercise imaging, but only 11 patients (61%) had perfusion abnormalities. Of these 15 patients with increased regional (18)F-FDG uptake on exercise imaging, 8 (53%) had no discernible (18)F-FDG uptake, 5 (33%) had decreased (18)F-FDG uptake, and only 2 (13%) had persistent (18)F-FDG uptake on rest (18)F-FDG images. The summed (18)F-FDG uptake score significantly decreased, from 14.4 +/- 10.3 at exercise to 6.7 +/- 9.2 at rest (P = 0.01). Patients with persistent (18)F-FDG uptake at rest had more (18)F-FDG uptake and lower peak rate-pressure product at exercise, compared with patients with no residual (18)F-FDG uptake at rest.
Conclusion: Exercise-induced regional myocardial (18)F-FDG uptake is highly specific and sensitive for exercise-induced myocardial ischemia. Regional myocardial (18)F-FDG uptake may persist 24 h after an episode of exercise-induced myocardial ischemia in some patients.
Li M, Boktor R, Rowe C, Weinberg L, Riedel B Front Nucl Med. 2024; 4:1412917.
PMID: 39513151 PMC: 11541950. DOI: 10.3389/fnume.2024.1412917.
Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.
Kersting D, Settelmeier S, Mavroeidi I, Herrmann K, Seifert R, Rischpler C Int J Mol Sci. 2022; 23(7).
PMID: 35409161 PMC: 8998973. DOI: 10.3390/ijms23073802.
Haider A, Haider A, Bengs S, Schade K, Wijnen W, Portmann A J Clin Med. 2020; 9(7).
PMID: 32709049 PMC: 7408629. DOI: 10.3390/jcm9072279.
Dual-time-point myocardial F-FDG imaging in the detection of coronary artery disease.
Dou K, Gao X, Xie B, Li Y, He Z, Yang M BMC Cardiovasc Disord. 2017; 17(1):120.
PMID: 28490354 PMC: 5424402. DOI: 10.1186/s12872-017-0554-x.
Direct myocardial ischemia imaging: a new cardiovascular nuclear imaging paradigm.
Jain D, He Z, Lele V, Aronow W Clin Cardiol. 2014; 38(2):124-30.
PMID: 25487883 PMC: 6711099. DOI: 10.1002/clc.22346.